Your browser doesn't support javascript.
loading
Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
Verwoerd, A; Hijdra, D; Vorselaars, A D M; Crommelin, H A; van Moorsel, C H M; Grutters, J C; Claessen, A M E.
Afiliación
  • Verwoerd A; Department of Pulmonology, Interstitial Lung Diseases Centre of Excellence.
  • Hijdra D; Department of Pulmonology, Interstitial Lung Diseases Centre of Excellence.
  • Vorselaars AD; Department of Medical Microbiology and Immunology.
  • Crommelin HA; Department of Pulmonology, Interstitial Lung Diseases Centre of Excellence.
  • van Moorsel CH; Department of Pulmonology, Interstitial Lung Diseases Centre of Excellence.
  • Grutters JC; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein.
  • Claessen AM; Department of Pulmonology, Interstitial Lung Diseases Centre of Excellence.
Clin Exp Immunol ; 185(2): 263-70, 2016 08.
Article en En | MEDLINE | ID: mdl-27158798
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoidosis / Linfocitos T Reguladores / Receptores Tipo II del Factor de Necrosis Tumoral / Infliximab Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoidosis / Linfocitos T Reguladores / Receptores Tipo II del Factor de Necrosis Tumoral / Infliximab Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Immunol Año: 2016 Tipo del documento: Article